BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 424439)

  • 1. Modifications of DOPAC levels in the striatum and olfactory tubercles of the rat after muscimol.
    Restelli A; Zambotti F; Vicentini L; Zonta N; Mantegazza P
    Pharmacol Res Commun; 1979 Jan; 11(1):55-9. PubMed ID: 424439
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydroxyphenylacetic acid conjugate: natural occurrence and demonstration of probenecid-induced accumulation in rat striatum, olfactory tubercles and frontal cortex.
    Elchisak MA; Maas JW; Roth RH
    Eur J Pharmacol; 1977 Feb; 41(4):369-78. PubMed ID: 844481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal DOPAC elevation predicts antipsychotic efficacy of metoclopramide.
    Stanley M; Wilk S
    Life Sci; 1979 May; 24(20):1907-12. PubMed ID: 459691
    [No Abstract]   [Full Text] [Related]  

  • 4. The differential effects of morphine, oxotremorine and antipsychotic drugs on DOPAC concentrations in rat brain.
    Stanley M; Wilk S
    J Pharm Pharmacol; 1980 Aug; 32(8):567-70. PubMed ID: 6106695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid post mortem changes in 3,4-dihydroxyphenylacetic acid (DOPAC), a dopamine metabolite, in rat striatum.
    Moleman P; Bruinvels J; Westerink BH
    J Neurochem; 1977 Jul; 29(1):175-7. PubMed ID: 886321
    [No Abstract]   [Full Text] [Related]  

  • 6. Catalepsy, DOPAC, and acetylcholine during chronic fluphenazine administration.
    Bowers MB; Bowers SM
    Commun Psychopharmacol; 1978; 2(6):533-7. PubMed ID: 570903
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of probenecid on endogenous and exogenous 3,4-dihydroxyphenylacetic acid and homovanillic acid in the rat brain.
    Broch OJ
    Eur J Pharmacol; 1976 Sep; 39(1):33-40. PubMed ID: 964303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of muscimol, a central GABA receptor agonist, on the catalepsy, striatal homovanillic acid increase, and analgesia induced by pilocarpine in rats.
    Naik SR; Kelkar MR; Amladi SR; Sheth UK
    Psychopharmacology (Berl); 1981; 74(4):393-4. PubMed ID: 6794090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of HVA and DOPAC in mouse corpus striatum in the supersensitivity phase after neuroleptic treatment.
    Hyttel J
    J Neurochem; 1977 Jan; 28(1):227-8. PubMed ID: 833596
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels.
    Meller E; Friedhoff AJ; Friedman E
    Life Sci; 1980 Feb; 26(7):541-7. PubMed ID: 7366335
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of various centrally acting drugs on the efflux of dopamine metabolites from the rat brain.
    Westerink BH; Kikkert RJ
    J Neurochem; 1986 Apr; 46(4):1145-52. PubMed ID: 3950621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.
    Roth RH; Murrin LC; Walters JR
    Eur J Pharmacol; 1976 Mar; 36(1):163-71. PubMed ID: 177297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
    Groppetti A; Parenti M; Galli CL; Bugatti A; Cattabeni F; Di Giulio AM; Racagni G
    Life Sci; 1978 Oct; 23(17-18):1763-8. PubMed ID: 31531
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine metabolism in the tuberculum olfactorium.
    Wilk S; Watson E; Glick SD
    Eur J Pharmacol; 1975 Jan; 30(1):117-20. PubMed ID: 1122932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of LSD and 2-bromo LSD on striatal DOPAC levels.
    Persson SA
    Life Sci; 1977 Apr; 20(7):1199-205. PubMed ID: 15175
    [No Abstract]   [Full Text] [Related]  

  • 16. Turnover of free and conjugated (sulphonyloxy) dihydroxyphenylacetic acid and homovanillic acid in rat striatum.
    Dedek J; Baumes R; Tien-Duc N; Gomeni R; Korf J
    J Neurochem; 1979 Sep; 33(3):687-95. PubMed ID: 479883
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of morphine to increase striatal 3,4-dihydroxyphenylacetic acid in fasted rats.
    De Montis GM; Olianas MC; Di Lorenzo C; Tagliamonte A
    Eur J Pharmacol; 1978 Jan; 47(1):121-3. PubMed ID: 618726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) content in mice.
    Saitoh T; Mizuno Y; Nagatsu T; Yoshida M
    Neurosci Lett; 1988 Oct; 92(3):321-4. PubMed ID: 3200488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bicuculline insensitive effects of baclofen.
    Rägo LK; Zarkovsky AM
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):166-9. PubMed ID: 6306483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.